You are here

Post Market Surveillance to Observe Safety of Prevenar13™ in Adults

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Chungnam National University Hospital (CNUH)
Jung-gu, Daejeon, 35015 Korea, Republic of
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pneumococcal Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Korean adults aged 18 years and older; provided the conditions pertaining to
contraindications, warnings, precautions, and interactions stated in the local product
document do not apply.

- Evidence of a personally signed and dated informed consent document indicating that
the subject(or a legally acceptable representative) has been informed of all pertinent
aspects of the study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

Subjects who are not indicated and/or contraindicated for the Prevenar13 usage will not be
included.

NCT01834222
Pfizer
Completed
Post Market Surveillance to Observe Safety of Prevenar13™ in Adults

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now